Medicare Enrolled
Dr. Marina Dolmatova, ARNP
Medical-Surgical Registered Nurse · Puyallup, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dolmatova from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dolmatova?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dolmatova
Dr. Marina Dolmatova is a medical-surgical registered nurse in Puyallup, WA, with 6 years of NPI registration. Based on federal Medicare data, Dr. Dolmatova performed 9,460 Medicare services across 4,922 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dolmatova received a total of $7,666 from 25 pharmaceutical and/or device companies across 324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical-surgical registered nurse. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dolmatova is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 6 years in practice
▲ Top 10% volume in WA
$7,666 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,460
Medicare services
Top 10% in WA for medical-surgical registered nurse
4,922
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,577 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
4,345 | $4 | $17 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,300 | $45 | $230 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
976 | $29 | $168 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
579 | $64 | $330 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
539 | $53 | $266 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
369 | $51 | $285 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
319 | $30 | $135 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
278 | $89 | $423 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
147 | $87 | $425 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
101 | $1 | $16 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
92 | $66 | $290 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
78 | $185 | $790 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
68 | $29 | $145 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
52 | $36 | $254 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
42 | $48 | $229 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
41 | $78 | $634 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
29 | $42 | $185 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
27 | $9 | $50 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
26 | $27 | $144 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
20 | $87 | $721 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
18 | $77 | $333 |
| Lip biopsy A procedure to remove a small sample of tissue from the lip for laboratory examination. |
14 | $72 | $322 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,666
Total received (2021-2024)
Avg $1,917/year across 4 years
Top 11% in WA for medical-surgical registered nurse
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
324
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,541 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$125 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,358
2023
$2,703
2022
$1,104
2021
$502
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$815
ABBVIE INC.
$693
Amgen Inc.
$324
SUN PHARMACEUTICAL INDUSTRIES INC.
$243
UCB, Inc.
$190
Regeneron Healthcare Solutions, Inc.
$185
E.R. Squibb & Sons, L.L.C.
$163
PFIZER INC.
$155
Dermavant Sciences, Inc.
$131
Organon Llc
$116
Sandoz Inc.
$81
Novartis Pharmaceuticals Corporation
$71
Lilly USA, LLC
$61
Organogenesis Inc.
$49
GENZYME CORPORATION
$40
Incyte Corporation
$25
Biofrontera Inc.
$17
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$1,839
ABBVIE INC.
$1,445
Regeneron Healthcare Solutions, Inc.
$717
Amgen Inc.
$494
E.R. Squibb & Sons, L.L.C.
$418
PFIZER INC.
$376
GENZYME CORPORATION
$301
Lilly USA, LLC
$287
SUN PHARMACEUTICAL INDUSTRIES INC.
$260
Dermavant Sciences, Inc.
$221
UCB, Inc.
$190
Novartis Pharmaceuticals Corporation
$165
AbbVie Inc.
$160
Sun Pharmaceutical Industries Inc.
$125
Janssen Scientific Affairs, LLC
$121
Organon Llc
$116
Sandoz Inc.
$81
Organon LLC
$72
Incyte Corporation
$68
Kyowa Kirin, Inc.
$52
Organogenesis Inc.
$49
Arcutis Biotherapeutics, Inc.
$41
Biofrontera Inc.
$27
Helsinn Therapeutics (U.S.), Inc.
$22
STRATA Skin Sciences, Inc.
$20
Top 3 companies account for 52.2% of all-time payments
Associated products mentioned in payments ›
AMELUZ · BLU-U · Bimzelx · CIBINQO · COSENTYX · DUPIXENT · EUCRISA · HADLIMA · HUMIRA · HYRIMOZ · ILUMYA · LIBTAYO · LITFULO · OLUMIANT · OPZELURA · Otezla · Poteligeo · RINVOQ · SKYRIZI · Sotyktu · TALTZ · TREMFYA · VALCHLOR · VTAMA · XTRAC
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical-surgical registered nurses within 10 mi
17
Per 100K population
1.8
County median income
$96,632
Nearest hospital
MULTICARE GOOD SAMARITAN HOSPITAL
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dolmatova is a clinical cardiology specialist, with above-average Medicare volume (top 10% in WA), with low-engagement industry engagement in the top 11% of WA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dolmatova experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Dolmatova performed 4,345 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dolmatova receive payments from pharmaceutical companies?
Yes. Dr. Dolmatova received a total of $7,666 from 25 companies across 324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dolmatova's costs compare to other medical-surgical registered nurses in Puyallup?
Dr. Dolmatova's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dolmatova) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical-Surgical Registered Nurses in Puyallup
Browse medical-surgical registered nurses in Puyallup ranked by procedure volume and transparency data.
Highest volume
Top Medical-Surgical Registered Nurses in WA
Medical-surgical registered nurses ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical-Surgical Registered Nurses in WA
Which WA medical-surgical registered nurses receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology